Adenocarcinoma and papilloma adenocarcinoma of rectum

C3_RECTUM_ADENO

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Cause of death: ICD-10 — C20.92& Cancer registry: Topography ICD-O-3 — C19\|C20 Cancer registry: Morphology ICD-O-3 — 8140 Cancer registry: Behaviour codes — 3 2 out of 7 registries used, show all original rules.	3570
4. Check minimum number of events None	3570
5. Include endpoints None	3570
6. Filter based on genotype QC (FinnGen only)	3570

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF8

NAME	C3_RECTUM_ADENO
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C2092
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C19\|C20
CANC_TOPO_EXCL
CANC_MORPH	8140
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Adenocarcinoma and papilloma adenocarcinoma of rectum based on the number of shared cases.

Similar with more cases:

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum
Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)
Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)
Colorectal adenocarcinoma
Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	28800	11906	16255
Only index persons	17730	7604	10126
Unadjusted period prevalence (%)
Whole population	0.41	0.34	0.45
Only index persons	0.34	0.28	0.39
Median age at first event (years)
Whole population	68.80	69.27	68.50
Only index persons	68.69	68.89	68.54

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3570	1326	2244
Unadjusted period prevalence (%)	0.79	0.45	0.99
Median age at first event (years)	67.77	66.20	68.70

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3307: Matched controls
33067

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

B01AB05

ATC

enoxaparin; parenteral

4.4

323.0

1809

7168

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

210.6

323.0

423

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

947.8

323.0

341

TJF80

NOMESCO Finland

Ostomy education

72.6

323.0

436

C20

ICD-10 Finland

Malignant neoplasm of rectum

488.4

323.0

702

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

323.0

423

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

152.9

323.0

622

130

Kela drug reimbursment

Malignant tumour

21.6

323.0

1790

1709

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

11.7

323.0

889

1003

L01BC06

ATC

capecitabine; oral

62.1

323.0

1472

422

WX302

NOMESCO Finland

Thoracal epidural anesthesy

19.8

323.0

1066

777

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

259.2

323.0

487

WF001

NOMESCO Finland

Preoperative radiotherapy

270.7

323.0

770

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

330.9

323.0

575

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

70.5

323.0

398

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

342.7

323.0

469

A04AA02

ATC

granisetron; systemic, transdermal

10.6

323.0

810

983

UJF32

NOMESCO Finland

Coloscopy

10.4

323.0

2294

5924

JG1BG

NOMESCO Finland

MRI of rectum

376.1

323.0

533

JFF23

NOMESCO Finland

Transversostomy

107.7

323.0

697

Z93.3

ICD-10 Finland

Colostomy status

102.1

323.0

435

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

474.4

323.0

1532

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

4503599627370496.0

323.0

2884

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

2277.2

323.0

2785

A03FA01

ATC

metoclopramide; systemic, rectal

7.2

323.0

1671

4111

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

118.3

323.0

387

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

21.3

323.0

1615

1416

JN4BD

NOMESCO Finland

Extensive body CT

7.6

323.0

1194

2291

JG1CG

NOMESCO Finland

Extensive MRI of rectum

254.9

323.0

423

D75

ICPC

Malignant neoplasm colon/rectum

68.0

315.6

364

H02AB02

ATC

dexamethasone; systemic

6.2

296.8

912

1898

UJG02

NOMESCO Finland

Proctoscopy

20.6

284.7

437

243

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

348.0

284.4

284

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

13.0

280.6

521

468

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

9.7

260.9

566

686

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

10.9

253.4

514

548

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

15.0

246.8

428

325

WX408

NOMESCO Finland

General anesthesy, balanced

3.6

235.9

1463

5929

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

14.3

232.5

411

325

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

8.1

230.9

564

823

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

3.4

225.1

1568

6891

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

140.4

221.6

235

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

95.4

216.5

239

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

16.9

211.4

347

227

WZC30

NOMESCO Finland

Teaching

4.4

211.1

899

2569

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

229.7

210.2

215

JN4AD

NOMESCO Finland

Body CT examination

5.4

209.2

710

1594

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

14.2

202.6

358

280

WX600

NOMESCO Finland

Single shot through catheter

28.6

197.3

272

103

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

10.5

194.7

400

428

JGB31

NOMESCO Finland

Laparoscopic and perineal excision of rectum

295.3

192.2

194

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

230.0

190.5

195

XX3DW

NOMESCO Finland

Time consuming IT work

4.5

183.8

750

2022

JGB04

NOMESCO Finland

Laparoscopic partial proctectomy with partial excision of mesorectum

305.7

171.5

173

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

17.7

164.2

264

161

ZX095

NOMESCO Finland

Combined chemoradiotherapy

42.1

160.8

202

JFF10

NOMESCO Finland

Loop enterostomy

57.5

160.3

190

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

12.5

158.1

295

257

TPH07

NOMESCO Finland

Cathetrisation of artery

4.0

154.5

722

2172

ZXE20

NOMESCO Finland

More than three and less than five hours

3.4

141.6

833

2998

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

7.4

139.4

352

522

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

17.7

136.0

218

131

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

6.4

128.5

364

631

SPAT1125

SPAT

Stoma care and guidance

11.4

128.4

250

236

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

7.0

127.5

335

524

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

65.8

125.1

145

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

6.0

123.4

364

664

WX402

NOMESCO Finland

General anaesthesia

3.1

118.8

771

2932

Z93

ICD-10 Finland

Artificial opening status

95.8

116.9

129

JN4CD

NOMESCO Finland

Very extensive body CT

5.6

112.2

352

690

ZX070

NOMESCO Finland

Intensity modified radiotherapy

8.8

109.9

247

302

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

10.1

109.2

225

236

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

5.0

108.9

380

839

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

4.7

107.8

398

933

JGB37

NOMESCO Finland

Laparoscopic wide excision of rectum

263.1

100.3

102

B01AB10

ATC

tinzaparin; parenteral

3.9

97.0

435

1222

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

10.7

96.2

192

189

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

8.5

95.4

218

273

SPAT1262

SPAT

Handing over of treatment supplies

2.5

94.4

895

4219

N02AA05

ATC

oxycodone; systemic

2.7

94.3

775

3367

TPX10

NOMESCO Finland

Implantation of vascular injection port

6.9

93.4

246

382

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

4.4

93.3

369

921

D18

ICPC

Change in faeces/bowel movements

8.8

89.5

199

238

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.1

87.5

559

2055

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

8.6

86.1

194

237

ZX090

NOMESCO Finland

Other technic of radiotherapy

6.2

85.3

242

415

JGB36

NOMESCO Finland

Wide excision of rectum

180.6

84.6

ZXC96

NOMESCO Finland

Robot assisted procedure

6.3

84.4

237

401

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

12.9

83.7

152

123

JF2AB

NOMESCO Finland

Colongraphy with X-ray

45.7

82.9

102

JGB01

NOMESCO Finland

Laparoscopic partial proctectomy and colorectal or coloanal anastomosis

148.8

82.4

1541A

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,INVASIIVINEN KARSINOOMA]

807.3

80.8

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

4.5

79.0

298

706

Z43.3

ICD-10 Finland

Attention to colostomy

48.8

78.2

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

9.0

77.1

169

197

TQW40

NOMESCO Finland

Remowal of suture of skin

3.6

76.8

376

1127

369

Kela drug reimbursment

Regorafenib

69.4

76.7

A04AA01

ATC

ondansetron; systemic, rectal

3.7

76.4

364

1067

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

78.4

74.4

L01BC59

ATC

trifluridine, combinations; systemic

59.5

74.1

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

59.5

74.1

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

21.0

73.4

110

WX306

NOMESCO Finland

Lumbar epidural anesthesy

4.8

73.4

263

590

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.9

73.3

502

1917

Z51.5

ICD-10 Finland

Palliative care

3.4

71.1

384

1241

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

53.1

69.4

JN3AD

NOMESCO Finland

Abdominal CT examination

3.1

68.6

420

1485

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

52.5

68.4

D99

ICPC

Disease digestive system other

11.5

67.1

128

115

ZX120

NOMESCO Finland

Intravenous

2.9

65.6

448

1699

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

20.3

64.2

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

8.6

63.3

142

172

JG1DG

NOMESCO Finland

Very extensive MRI of rectum

136.7

63.1

176

Kela drug reimbursment

Regorafenib

51.1

62.4

N02BE01

ATC

paracetamol; systemic, rectal

2.2

62.0

2840

24226

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.3

61.9

338

1097

JG1CM

NOMESCO Finland

Extensive MRI of rectum (more than 1.5 T)

598.4

59.9

JAH00

NOMESCO Finland

Laparotomy

5.1

59.3

197

406

JGB20

NOMESCO Finland

Partial rectosigmoidectomy and abdominoperineal pull-through anastomosis

296.9

57.4

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

28.5

57.2

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

57.0

830

4615

JJB10

NOMESCO Finland

Atypcal resection of liver

42.0

56.2

Z43.2

ICD-10 Finland

Attention to ileostomy

38.1

55.8

1XC07

NOMESCO Finland

37.6

54.9

JFF27

NOMESCO Finland

Laparoscopic sigmoidostomy

70.0

54.3

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.4

54.1

288

914

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

5.2

52.8

172

347

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

14.3

51.7

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

6.8

51.4

134

204

R4110

NOMESCO Finland

Physiotherapy

1.9

51.4

971

5927

K45.8

ICD-10 Finland

Other specified abdominal hernia without obstruction or gangrene

15.0

50.5

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

6.5

50.2

135

215

WF049

NOMESCO Finland

Radiotherapy of metastasis

4.0

49.9

212

558

JFB00

NOMESCO Finland

Partial resection of small intestine

6.6

48.4

128

199

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

10.8

46.6

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.7

45.9

213

605

Z93.2

ICD-10 Finland

Ileostomy status

22.4

45.3

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

20.4

45.3

JGA73

NOMESCO Finland

Transanal excision of lesion of rectum

33.3

45.1

JFF24

NOMESCO Finland

Laparoscopic transversostomy

99.4

44.9

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.0

44.6

271

942

WF004

NOMESCO Finland

Palliative radiotherapy

5.2

44.5

143

284

E0000UV

ATC

1.7

43.8

1218

8335

K56.7

ICD-10 Finland

Ileus, unspecified

5.6

43.7

132

244

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

3.4

43.7

221

673

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

42.1

1258

8765

L01XE21

ATC

[U] regorafenib; oral

69.4

42.1

C21.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of rectum, anus and anal canal

114.0

41.8

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

5.5

41.7

128

241

JN2CM

NOMESCO Finland

Lower part of abdomen extensive MRI examination with Tesla magnet

12.5

41.4

JN2BD

NOMESCO Finland

Extensive CT exmaniation of lower part of abdomen

26.3

41.1

B01AB04

ATC

dalteparin; parenteral

3.1

40.7

240

817

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

9.7

40.6

6434

FHL

Anterior resection

65.1

39.1

JJB50

NOMESCO Finland

Excision of segments V, VI, VII and VIII of liver

36.2

39.1

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

14.4

38.2

6435

FHL

Abdominoperineal resection and colostomy

197.1

37.9

WW500

NOMESCO Finland

Blood transfusion

3.3

37.3

202

647

JFF26

NOMESCO Finland

Sigmoidostomy

34.7

37.2

A04AD12

ATC

aprepitant; systemic

5.3

37.1

117

228

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

4.6

36.7

133

301

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

13.6

36.7

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

5.4

36.0

112

215

XJG12

NOMESCO Finland

Transrectal endoscopic ultrasonography

44.5

35.9

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.8

35.4

159

439

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

20.3

34.8

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

31.1

34.8

A79

ICPC

Malignancy NOS

6.0

34.1

163

Z51.0

ICD-10 Finland

Radiotherapy session

5.9

34.1

167

JG001

NOMESCO Finland

Preopertaive radiotherapy of rectum

340.5

34.0

N03AX16

ATC

pregabalin; oral

1.8

33.9

775

4920

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

10.5

33.6

WX704

NOMESCO Finland

Intubation

2.5

33.5

273

1132

D01.2

ICD-10 Finland

Carcinoma in situ: Rectum

+∞

33.4

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

7.3

33.2

113

A04AA55

ATC

palonosetron, combinations; systemic

4.1

33.2

133

332

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

32.7

811

5268

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

37.7

32.4

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

20.3

32.2

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.7

32.0

144

399

JGB11

NOMESCO Finland

Laparoscopic partial proctectomy and end colostomy

319.9

31.9

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

3.3

31.1

165

521

WF002

NOMESCO Finland

Radical radiotherapy

2.5

30.0

247

1030

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.6

29.9

234

948

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

4.1

29.8

119

297

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

16.2

29.8

JJB30

NOMESCO Finland

Excision of two segments of liver

37.4

29.3

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

10.7

28.9

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

8.9

28.9

WF003

NOMESCO Finland

Adjuvant radiotherapy

3.2

28.4

158

517

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

28.2

435

2402

UJF30

NOMESCO Finland

Ileoscopy through colon

2.1

28.1

330

1633

V03AF03

ATC

calcium folinate; systemic

23.2

27.4

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.4

27.4

139

425

K92.1

ICD-10 Finland

Melaena

2.4

27.3

239

1028

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.9

27.1

116

308

JAG41

NOMESCO Finland

Repair of stomal hernia, laparoscopic

75.7

26.8

D16

ICPC

Rectal bleeding

4.2

26.7

105

259

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

10.8

26.5

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

3.5

26.4

128

378

JWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery

21.3

26.0

LEC00

NOMESCO Finland

Partial excision of vagina

60.5

26.0

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

10.1

25.7

L01BC53

ATC

tegafur, combinations; systemic

25.2

TJG20

NOMESCO Finland

Transanal irrigation

22.7

25.2

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

4.6

25.1

194

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

3.8

24.8

108

292

C209

ICD-10 Finland

70.4

24.8

JAH01

NOMESCO Finland

Laparoscopy

3.0

24.8

145

492

15411

ICD-8 Finland

Malignant neoplasm of rectum and rectosigmoid junction, Rectum

251.9

24.7

XX1AD

NOMESCO Finland

Other CT-examination

8.8

24.2

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

6.7

24.2

R4190

NOMESCO Finland

Nutritional therapy

3.3

24.2

125

388

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

4.1

23.9

232

S18

ICPC

Laceration/cut

1.5

23.5

1342

10492

JJB71

NOMESCO Finland

Laparoscopic resection of liver

33.6

23.3

ZXD05

NOMESCO Finland

Urgent procedure

1.5

23.2

970

7093

JG1BM

NOMESCO Finland

MRI of rectum (more than 1.5 T)

+∞

22.9

1541X

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,EI HISTOLOGISTA VAHVISTUSTA]

+∞

22.9

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

32.5

22.4

Z3231

NOMESCO Finland

Registered nurse

1.5

21.9

865

6227

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

7.4

21.9

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

12.3

21.8

XJA00

NOMESCO Finland

Intraoperative abdominal ultrasonography

25.2

21.7

JFB54

NOMESCO Finland

Laparoscopic resection of sigmoid colon with partial proctectomy

18.5

21.7

Z31.5

ICD-10 Finland

Genetic counselling

3.2

21.7

119

387

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

14.5

21.6

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

8.0

21.2

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.4

21.0

187

810

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

4.4

21.0

174

JFB53

NOMESCO Finland

Resection of sigmoid colon with partial proctectomy

28.2

20.9

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

8.6

20.8

D28

ICPC

Limited function/disability (D)

14.1

20.8

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

4.9

20.5

138

JFF30

NOMESCO Finland

Other colostomy

25.6

20.4

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

19.9

1180

9207

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.4

19.8

166

ZX080

NOMESCO Finland

Image guided radiotherapy

3.5

19.5

267

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

19.5

229

1127

C18.9

ICD-10 Finland

Malignant neoplasm: Colon, unspecified

21.7

19.5

R03AC02

ATC

salbutamol; inhalant

0.7

19.4

920

11798

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

3.6

19.2

240

JWW96

NOMESCO Finland

Other reoperation in gastroenterological surgery

16.8

19.1

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

19.1

264

1393

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

3.0

19.0

111

377

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

4.9

18.9

129

JN2DM

NOMESCO Finland

Lower part of abdomen very extensive MRI examination with Tesla magnet

9.2

18.8

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

4.1

18.8

180

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

18.4

557

3745

JJB20

NOMESCO Finland

Excision of single segment of liver

30.2

18.3

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.1

18.3

104

345

P01AB01

ATC

metronidazole; oral, rectal

1.4

18.2

1063

8236

JHA00

NOMESCO Finland

Anal or perianal incision

4.8

18.0

127

JAG43

NOMESCO Finland

Repair of stomal hernia with mesh

52.8

17.9

JA3CT

NOMESCO Finland

Cathetrisation of abdominal cavity with CT guidance

26.8

17.8

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.3

17.8

171

770

NET99

NOMESCO Finland

Other operation on pelvis

66.9

17.7

WX725

NOMESCO Finland

Noninvasive ventilation

2.3

17.7

160

700

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.4

17.7

262

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

17.7

572

3904

TPX15

NOMESCO Finland

Removal of vascular injection port

8.5

17.6

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

10.4

17.6

K43.5

ICD-10 Finland

Parastomal hernia without obstruction or gangrene

36.9

17.6

JEA00

NOMESCO Finland

Appendectomy

2.2

17.5

183

860

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.4

17.5

150

639

D17

ICPC

Incontinence of bowel

5.8

17.3

T81.9

ICD-10 Finland

Unspecified complication of procedure

3.7

17.3

209

R19.4

ICD-10 Finland

Change in bowel habit

3.1

17.0

304

D29

ICPC

Digestive symptom/complaint other

3.6

16.9

219

Z71.8

ICD-10 Finland

Other specified counselling

1.5

16.8

606

4237

1XC08

NOMESCO Finland

63.6

16.7

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

4.6

16.5

126

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.1

16.5

196

974

UJF34

NOMESCO Finland

Left colonoscopy

6.0

16.4

WX110

NOMESCO Finland

Local anesthesy

1.4

16.4

1862

16069

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

16.4

175

829

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

20.1

16.4

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

5.1

16.3

101

JJB60

NOMESCO Finland

Other excsion of three or more segments of liver

40.3

16.3

K61.1

ICD-10 Finland

Rectal abscess

12.2

16.3

R50.9

ICD-10 Finland

Fever, unspecified

1.6

16.0

416

2679

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

16.0

1416

11720

K45.0

ICD-10 Finland

Other specified abdominal hernia with obstruction, without gangrene

21.0

16.0

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

21.0

16.0

A06AD11

ATC

lactulose; oral

1.6

15.9

508

3447

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

15.8

242

1323

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

6.6

15.8

Y83.2

ICD-10 Finland

Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

11.2

15.7

JFB20

NOMESCO Finland

Ileocaecal resection

7.6

15.6

JJB40

NOMESCO Finland

Excision of segments II, III and IV of liver

38.2

15.4

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.5

15.0

198

SPAT1153

SPAT

Removal of sutures

1.4

14.9

997

7849

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

4.5

14.8

117

J01MA12

ATC

levofloxacin; systemic

1.5

14.7

601

4307

JFG50

NOMESCO Finland

Laparotomy with revision of enterostomy or colostomy

25.1

14.7

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

9.7

14.7

N82.3

ICD-10 Finland

Fistula of vagina to large intestine

21.1

14.6

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

3.7

14.3

165

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.9

14.1

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

14.0

256

1489

LEE10

NOMESCO Finland

Repair of vagina using graft or flap

75.4

13.6

JFG30

NOMESCO Finland

Closure of colostomy with resection of exteriorised loop

14.7

13.6

JKA20

NOMESCO Finland

Cholecystectomy

2.4

13.5

116

497

JAD10

NOMESCO Finland

Repair of incisional hernia

4.6

13.3

ZX121

NOMESCO Finland

Central venous catheter

7.7

13.3

K56.0

ICD-10 Finland

Paralytic ileus

4.1

13.3

126

C18.91

ICD-10 Finland

Malignant tumor of unspecified location in colon invasive carcinoma

13.8

13.2

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

4.9

12.9

ZXE00

NOMESCO Finland

One hour or less

1.3

12.9

1120

9149

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

3.6

12.8

156

D77

ICPC

Malignant digestive neopl other/NOS

6.6

12.8

TJX90

NOMESCO Finland

Other minor procedure in gastroenterological surgery

14.1

12.7

C18

ICD-10 Finland

Malignant neoplasm of colon

14.1

12.7

WX882

NOMESCO Finland

High dependency care

2.4

12.7

104

435

K43.3

ICD-10 Finland

Parastomal hernia with obstruction, without gangrene

+∞

12.5

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

2.7

12.5

310

R33

ICD-10 Finland

Retention of urine

1.6

12.4

312

1986

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

12.3

472

3325

A02BC02

ATC

pantoprazole; systemic

1.3

12.3

1934

17157

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.3

12.3

116

522

WGA11

NOMESCO Finland

Planning of pain management

14.4

12.2

A06AH03

ATC

naloxegol; oral

3.6

12.2

152

K46.9

ICD-10 Finland

Unspecified abdominal hernia without obstruction or gangrene

5.8

12.1

KCC10

NOMESCO Finland

Cystoprostatectomy

5.6

12.1

JFB46

NOMESCO Finland

Resection of sigmoid colon

3.6

11.9

150

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

4.4

11.8

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

11.7

244

1474

JGA98

NOMESCO Finland

Other transluminal endoscopic local operation on rectum

16.4

11.6

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

4.3

11.6

1540A

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectosigmoid junction[NEOPL MALIG JUNCT RECTOSIGM,INVASIIVINEN KARSINOOMA]

+∞

11.5

178

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

13.6

11.4

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.1

11.4

199

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

8.9

11.2

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

3.2

11.2

180

LCD00

NOMESCO Finland

Hysterectomy

2.3

11.2

104

467

R01AD09

ATC

mometasone; nasal

0.7

11.1

696

8737

JGA75

NOMESCO Finland

Endoscopic microsurgical excision of lesion of rectum

20.1

11.1

A28

ICPC

Limited function/disability NOS

1.4

11.1

502

3658

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.7

11.0

509

6683

G47.3

ICD-10 Finland

Sleep apnoea

0.7

11.0

325

4603

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

3.7

10.9

130

G04CA02

ATC

tamsulosin; oral

1.3

10.9

918

7423

JAG00

NOMESCO Finland

Repair of other hernia

11.9

10.8

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

10.6

10.7

JAG96

NOMESCO Finland

Other reconstruction of abdominal wall

10.6

10.7

GDB10

NOMESCO Finland

Wedge resection of lung

8.8

10.7

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.9

10.7

220

WX002

NOMESCO Finland

Sedation and analgesia

1.4

10.6

577

4342

JF2CG

NOMESCO Finland

Extensive MRI of colon

60.2

10.6

Z93.4

ICD-10 Finland

Other artificial openings of gastrointestinal tract status

60.2

10.6

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.7

10.6

456

6061

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

5.1

10.6

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

6.0

10.6

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

10.5

438

3139

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

10.5

391

2737

KBV00

NOMESCO Finland

Insertion of stent into ureter

5.0

10.4

L03AA02

ATC

filgrastim; parenteral

2.4

10.3

353

JFB30

NOMESCO Finland

Right hemicolectomy

2.9

10.3

207

L01BC04

ATC

carmofur; oral

32.6

10.3

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

4.4

10.3

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

6.0

10.3

KBH20

NOMESCO Finland

Replantation of ureter

10.6

10.3

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

10.0

872

7070

JFH20

NOMESCO Finland

Proctocolectomy and ileostomy

14.6

10.0

UJH02

NOMESCO Finland

Anoscopy

2.0

10.0

123

622

JGA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in rectum

12.2

9.8

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

3.5

9.8

127

JGA96

NOMESCO Finland

Other proctotomy or local operation on rectum

20.1

9.8

M01AE02

ATC

naproxen; oral, rectal

0.8

9.7

1097

12812

J01MA02

ATC

ciprofloxacin; systemic

1.3

9.7

1169

9901

M25.5

ICD-10 Finland

Pain in joint

0.7

9.6

393

5278

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

5.3

9.6

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

5.3

9.6

UJF32

SPAT

3.0

9.6

187

R03DC03

ATC

montelukast; oral

0.6

9.5

156

2499

JJA43

NOMESCO Finland

Destruction of lesion of liver

100.3

9.4

JJ7LT

NOMESCO Finland

Coagulation of focal hepatic lesion under CT guidance

30.1

9.4

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

0.7

9.4

519

6650

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

3.4

9.3

127

JFA42

NOMESCO Finland

Endoscopic injection in colon

5.6

9.3

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

9.3

165

953

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

3.8

9.3

JFA70

NOMESCO Finland

Suture of small intestine

8.7

9.3

JN2AD

NOMESCO Finland

CT examination of lower part of abdomen

10.7

9.3

H03AA01

ATC

levothyroxine sodium; systemic

0.7

9.2

317

4380

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.7

9.1

376

5045

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.0

9.1

110

553

R11

ICD-10 Finland

Nausea and vomiting

1.7

9.1

202

1248

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

9.0

444

3277

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.4

8.9

121

WX892

NOMESCO Finland

Monitored bed care

1.6

8.9

234

1511

JHA10

NOMESCO Finland

Biopsy of anal canal

18.6

8.9

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

0.6

8.9

122

2040

Z85.0

ICD-10 Finland

Personal history of malignant neoplasm of digestive organs

8.0

8.8

SPAT1131

SPAT

Colonoscopy

2.0

8.8

106

534

R19.5

ICD-10 Finland

Other faecal abnormalities

3.0

8.8

156

A07DA03

ATC

loperamide; oral

1.9

8.8

118

619

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

9.5

8.8

R07.4

ICD-10 Finland

Chest pain, unspecified

0.7

8.8

504

6433

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

0.7

8.7

537

6791

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.9

8.7

116

608

N32.1

ICD-10 Finland

Vesicointestinal fistula

7.2

8.7

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

8.7

222

1423

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.6

8.5

197

1231

L01EX05

ATC

regorafenib; oral

20.1

8.5

GDB20

NOMESCO Finland

Segmental resection of lung

20.1

8.5

R05FB02

ATC

cough suppressants and expectorants

0.8

8.4

760

9158

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

2.3

8.4

345

R03BA05

ATC

fluticasone; inhalant

0.7

8.4

236

3382

JGA58

NOMESCO Finland

Endoscopic insertion of prosthetic tube into rectum

90.2

8.4

M01AH05

ATC

etoricoxib; oral

0.8

8.4

1153

13249

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

8.4

318

JGB97

NOMESCO Finland

Other laparoscopic proctectomy or excision of rectum

+∞

8.3

R06.0

ICD-10 Finland

Dyspnoea

0.7

8.3

440

5688

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

5.2

8.3

K60.4

ICD-10 Finland

Rectal fistula

10.8

8.3

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

5.5

8.3

JFB63

NOMESCO Finland

Other resection of colon with proximal colostomy and closure of distal stump

14.5

8.2

M03BC51

ATC

orphenadrine, combinations; systemic

0.7

8.2

418

5428

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

8.2

125

688

M01AC06

ATC

meloxicam; systemic, rectal

0.8

8.1

663

8087

Z93.8

ICD-10 Finland

Other artificial opening status

17.2

8.1

JJA20

NOMESCO Finland

Open biopsy of liver

6.8

8.0

R15

ICD-10 Finland

Faecal incontinence

2.2

8.0

333

JFK00

NOMESCO Finland

Division of adhesive band in intestinal obstruction

6.3

8.0

XJW99

NOMESCO Finland

Other investigative procedure on digestive system

6.3

8.0

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2748

3287

32.96

307.65

10.2

3.5

ug/l

35.2

21.5

0.62

2523

2704

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

791

1168

8.41

307.65

6.2

3.1

u/ml

673.6

4534.4

0.92

730

999

(3022145) Colonoscopy Study observation

1493

3086

7.60

307.65

1.6

1.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

973

2923

4.20

287.84

2.5

2.1

g/l

0.2

1.93

950

2703

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2424

13746

3.38

252.69

5.8

4.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

420

691

6.75

248.48

5.3

3.1

u/ml

55.9

939.0

1.49

376

636

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

980

3300

3.71

241.74

2.6

2.7

umol/l

7.7

9.3

1.35

915

2909

(3024561) Albumin [Mass/volume] in Serum or Plasma

2371

13516

3.25

239.82

11.3

4.8

g/l

32.9

34.8

43.32

2302

12494

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2610

15823

3.41

235.76

15.1

6.2

umol/l

11.1

12.2

4.06

2553

15016

(3044640) Blood type and Crossmatch panel - Blood

1835

9579

2.88

207.59

3.5

2.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1516

7367

2.84

193.10

3.3

2.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

795

2702

3.50

188.87

2.1

2.4

u/l

31.1

55.9

0.78

748

2291

(4035726)

781

2647

3.50

186.14

1.3

1.4

—

(3032080) INR in Blood by Coagulation assay

2253

13632

2.77

183.02

8.6

10.9

inr

1.2

1.3

14.20

603

3715

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1710

9397

2.57

163.00

2.6

u/l

57.1

59.0

0.80

1644

8640

(3014576) Chloride [Moles/volume] in Serum or Plasma

989

4310

2.79

148.68

10.1

6.7

mmol/l

105.0

104.3

4.85

979

4194

(3033658) Prothrombin time (PT) actual/Normal

1415

7627

2.42

133.97

5.1

4.1

90.5

85.1

14.19

1407

7451

(40768804) Tissue Pathology biopsy report

1842

11458

2.25

120.89

2.8

2.2

—

(3023368) Bacteria identified in Blood by Culture

1572

9417

2.20

110.22

5.2

4.4

—

(3037121) Protein [Mass/volume] in Urine

376

1104

3.69

108.53

6.7

2.9

g/l

0.2

0.3

3.58

293

430

(3013650) Neutrophils [#/volume] in Blood by Automated count

2350

16626

2.21

105.85

17.1

8.7

e9/l

3.9

4.3

14.99

2147

14395

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1459

8885

2.09

93.95

4.4

3.2

u/l

32.3

38.7

2.05

1422

8403

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2888

22740

2.41

93.13

16.4

7.7

u/l

89.5

80.2

11.26

2811

21344

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1017

5889

2.02

71.07

9.9

3.0

mmol/l

2.5

6.70

953

5142

(3003694) ABO and Rh group [Type] in Blood

1167

7143

1.94

69.08

1.4

1.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2338

18116

1.84

62.55

6.0

5.0

mmol/l

7.0

6.9

1.44

2265

17101

(3002256) Pathology report gross observation

732

3940

2.08

61.37

1.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

330

1275

2.75

58.83

2.7

u/ml

0.3

1.15

182

726

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

490

2312

2.30

56.94

1.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1493

10367

1.76

55.75

8.3

3.4

mmol/l

2.3

1.05

1367

8868

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

422

1885

2.40

55.55

9.2

9.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

878

5204

1.91

55.13

5.9

3.1

mmol/l

0.8

9.93

840

4840

(3002173) Hemoglobin [Mass/volume] in Arterial blood

613

3316

2.02

49.70

8.3

7.8

g/l

117.7

120.7

3.67

594

3195

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1886

14307

1.67

48.42

7.4

6.2

mmol/l

1.2

9.57

1744

12867

(40758558) Short blood count panel - Blood

1095

7283

1.73

45.40

13.6

6.5

—

(3016502) Oxygen saturation in Arterial blood

644

3655

1.93

45.06

8.1

7.3

96.9

95.3

10.03

621

3514

(3031040) Bacteria [#/volume] in Urine by Automated count

2386

19450

1.68

44.66

5.0

4.8

e6/l

2695.7

1322.2

0.28

338

(3003396) Base excess in Arterial blood by calculation

690

4037

1.88

43.87

7.9

7.1

mmol/l

1.1

0.04

579

3119

(3014111) Lactate [Moles/volume] in Serum or Plasma

553

3008

1.99

43.70

6.1

6.8

mmol/l

1.3

1.4

0.82

530

2897

(3027801) Oxygen [Partial pressure] in Arterial blood

690

4045

1.87

43.57

7.9

7.0

kpa

14.3

11.9

21.18

663

3850

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

690

4046

1.87

43.53

7.9

7.1

kpa

5.2

5.1

3.00

664

3851

(3002582) Erythrocytes [#/volume] in Urine

1367

9741

1.65

43.18

3.8

3.5

e6/l

114.7

94.3

0.20

1136

7627

(36304419) Bacteria [Presence] in Urine

1220

8521

1.66

41.21

3.6

3.3

—

(3030467) Casts [#/volume] in Urine by Automated count

1257

8868

1.64

40.69

3.7

3.4

e6/l

0.6

0.5

0.39

1029

6793

(3042936) Bacteria identified in Isolate by Culture

733

4471

1.80

40.38

2.3

2.0

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1991

15742

1.60

39.88

8.4

7.0

mmol/l

1.2

11.67

1675

13235

(3025941) Bacteria identified in Stool by Culture

301

1368

2.31

37.59

1.3

—

(3018095) Leukocytes [#/volume] in Urine

1448

10984

1.54

32.29

4.4

3.9

e6/l

181.5

113.6

1.60

1173

8111

(3000850) Epithelial cells [#/volume] in Urine

985

6870

1.60

31.73

2.8

2.7

e6/l

5.1

4.6

0.44

879

6043

(3026782) Osmolality of Urine

930

6420

1.61

31.19

3.2

2.9

mosm/kgh2o

529.0

557.3

4.39

833

5466

(3014007) Fractional oxyhemoglobin in Arterial blood

398

2185

1.92

29.97

8.7

8.9

95.1

93.8

5.27

398

2175

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

224

992

2.34

29.60

1.3

—

(3039000) Anion gap in Blood

187

769

2.51

29.09

8.7

7.0

mmol/l

11.0

11.2

0.74

169

689

(3018572) Chloride [Moles/volume] in Blood

187

769

2.51

29.09

8.7

7.0

mmol/l

106.4

105.2

3.61

169

689

(3026008) Bacteria identified in Urine by Culture

1250

9363

1.52

28.63

3.5

3.4

—

(3047181) Lactate [Moles/volume] in Blood

229

1056

2.25

27.50

7.8

6.2

mmol/l

1.4

1.3

0.33

203

933

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

679

4505

1.63

26.20

2.2

2.7

20.1

22.4

3.84

590

3848

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3061

27862

1.69

25.93

29.4

16.7

mg/l

37.7

26.7

45.86

2856

22672

(3000991) Gas panel - Venous blood

468

2835

1.75

25.40

7.3

8.2

—

(3048689) Calprotectin [Mass/mass] in Stool

448

2702

1.75

24.66

1.4

2.2

ug/g

273.9

163.1

4.07

352

2110

(3004789) Transferrin [Mass/volume] in Serum or Plasma

701

4787

1.58

23.72

2.2

2.6

g/l

2.3

3.24

658

4437

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

744

5158

1.56

23.54

3.6

3.2

e6/l

2.5

1.9

0.92

449

2909

(3008152) Bicarbonate [Moles/volume] in Arterial blood

380

2215

1.80

23.45

8.6

6.7

mmol/l

24.9

24.5

1.45

360

2068

(3037467) Urinalysis macro (dipstick) panel - Urine

2317

20018

1.45

23.40

5.7

4.5

—

(3022948) Iron [Moles/volume] in Serum or Plasma

740

5144

1.55

23.08

2.3

2.6

umol/l

11.5

12.5

3.36

694

4776

(3020779) Urea [Moles/volume] in Serum or Plasma

496

3164

1.66

22.06

4.9

7.1

mmol/l

9.6

11.0

3.32

472

2991

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

519

3375

1.63

21.35

5.1

3.7

—

(3019060) Gas panel - Arterial blood

392

2377

1.73

21.02

6.5

4.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

275

1525

1.87

19.87

2.0

1.9

ug/l

2.6

0.01

246

1330

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

757

5493

1.48

18.78

3.3

3.0

e6/l

1.0

1.1

0.31

455

3220

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

759

5533

1.47

18.34

1.8

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

315

1877

1.74

17.90

9.0

9.1

mmol/l

24.1

24.3

0.40

301

1743

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

260

1464

1.84

17.88

7.1

5.1

1.6

0.11

240

1377

(42870588) Differential panel, method unspecified - Blood

1257

10104

1.38

17.31

4.2

5.7

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

255

1442

1.83

17.29

7.2

5.2

0.9

2.22

236

1356

(3051651) Icteric interference index of Serum or Plasma

194

3.29

16.79

5.0

3.7

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1035

8139

1.38

16.03

2.2

mg/l

3.4

3.0

3.66

867

6885

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

138

653

2.16

15.60

1.3

—

(3018418) pH of Serum or Plasma

1162

9344

1.36

15.55

5.3

4.1

7.4

0.06

253

1788

(3006504) Eosinophils/100 leukocytes in Blood

1582

13408

1.32

14.55

4.4

6.0

2.7

2.9

2.59

1470

12415

(3022096) Basophils/100 leukocytes in Blood

1544

13050

1.32

14.45

4.4

6.0

0.6

0.7

10.28

1431

12101

(3019069) Monocytes/100 leukocytes in Blood

1586

13463

1.32

14.36

4.7

6.3

9.1

9.0

0.49

1474

12515

(3014765) Yersinia sp identified in Stool by Organism specific culture

148

756

2.00

13.68

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2521

27258

0.74

13.61

4.2

4.8

mmol/l

4.5

1.61

2257

24799

(42529406) Shigella sp [Presence] in Stool by Culture

148

761

1.99

13.43

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

146

748

1.99

13.39

1.2

—

(3002030) Lymphocytes/100 leukocytes in Blood

1603

13716

1.31

13.35

4.6

6.1

22.5

26.2

29.23

1472

12653

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2497

27009

0.75

13.26

4.2

4.7

mmol/l

1.4

1.61

2222

24379

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2436

26422

0.75

13.02

6.0

6.5

mmol/mol

41.0

40.9

0.27

2168

24120

(3018010) Neutrophils/100 leukocytes in Blood

1573

13516

1.29

12.35

4.3

5.9

61.2

58.4

12.91

1455

12548

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2609

27967

0.75

12.24

4.7

5.4

mmol/l

2.6

0.60

2317

25300

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

263

4030

0.62

12.01

1.2

u/ml

13.7

14.2

0.04

1441

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

282

4232

0.64

11.71

1.2

iu/ml

67.0

37.5

1.28

1288

(40762365) Oxygen content in Arterial blood by calculation

4.47

11.65

4.0

2.9

ml/dl

13.6

15.3

2.67

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

167

939

1.82

11.58

1.9

1.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

649

8314

0.73

11.34

2.5

2.9

umol/l

2526.9

6227.4

2.13

549

7052

(3006315) Basophils [#/volume] in Blood

1646

14324

1.28

11.33

4.3

5.6

e9/l

0.0

11.37

1405

12237

(3051611) Lipemic interference index of Serum or Plasma

336

2.35

11.13

4.9

3.6

—

(3001604) Monocytes [#/volume] in Blood

1635

14246

1.27

11.03

4.3

5.6

e9/l

0.6

1.57

1390

12146

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1336

11378

1.28

10.79

2.6

2.9

ug/l

173.2

159.7

0.38

1213

10348

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2817

26322

1.33

10.71

30.6

16.0

ml/min/173m2

77.7

74.6

14.41

2561

21926

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2433

26185

0.78

10.53

3.8

4.3

mmol/l

1.3

0.02

2142

23438

(3019550) Sodium [Moles/volume] in Serum or Plasma

3099

29418

1.40

10.42

35.5

19.9

mmol/l

139.2

139.6

18.58

3049

28644

(40768441) Liver Pathology biopsy report

197

2.72

10.30

1.1

1.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3103

29477

1.40

10.26

35.6

20.1

mmol/l

4.0

19.35

3053

28656

(3019198) Lymphocytes [#/volume] in Blood

1659

14575

1.26

10.11

4.4

5.7

e9/l

1.6

1.9

3.03

1434

12656

(40761511) CBC panel - Blood by Automated count

3010

28480

1.36

9.96

29.8

16.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

385

2.16

9.59

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

380

2.16

9.49

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

475

3551

1.39

9.46

1.8

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

388

2.14

9.41

1.4

—

(3013115) Eosinophils [#/volume] in Blood

1672

14784

1.25

9.35

4.4

5.8

e9/l

0.2

5.45

1454

12809

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

383

2.14

9.31

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

307

2125

1.49

9.30

1.8

1.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1900

17050

1.24

9.26

3.5

3.2

u/l

65.5

56.1

2.70

1779

15597

(3012501) Base excess in Blood by calculation

135

767

1.79

9.11

4.4

5.0

mmol/l

2.7

0.01

520

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

380

2.13

9.10

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

382

2.12

8.98

1.4

—

(3044889) 12 lead EKG panel

2257

20684

1.25

8.92

4.5

4.2

—

(3010421) pH of Blood

151

898

1.71

8.71

4.2

4.8

7.4

0.61

134

754

(40761536) Microorganisms panel - Urine sediment

336

2407

1.44

8.52

4.6

4.2

—

(3020891) Body temperature

212

1385

1.56

8.42

5.3

4.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

557

4346

1.33

8.39

4.4

5.9

mmol/l

1.0

0.22

518

4015

(3004716) Salmonella sp identified in Stool by Organism specific culture

165

1021

1.65

8.21

1.2

1.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

650

5207

1.30

8.09

2.1

2.0

30.2

30.1

0.28

634

5044

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1863

20392

0.82

7.83

3.2

3.8

pmol/l

15.0

0.19

1624

18183

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

278

1961

1.45

7.66

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

235

3353

0.68

7.49

1.2

1.3

titre

603.6

518.1

0.21

721

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

213

1433

1.52

7.43

2.0

1.9

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

165

1057

1.59

7.17

1.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

621

7568

0.78

6.97

1.6

1.7

mmol/l

1.5

1.3

1.23

502

6241

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

384

1.95

6.72

1.1

g/l

1.6

0.86

345

(3013512) EKG study

1091

9463

1.22

6.67

4.2

4.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

450

1.86

6.62

5.4

6.5

mg/l

12.0

12.1

0.04

417

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3070

29474

1.30

6.60

19.4

11.2

u/l

24.0

26.2

8.46

3002

28215

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

486

3845

1.31

6.56

1.6

1.8

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2601

27381

0.82

6.56

4.5

5.1

mmol/l

6.2

6.1

1.43

2301

24486

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

194

1318

1.50

6.50

2.0

1.8

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

160

2.45

6.34

1.8

1.7

u/field

2.9

2.7

0.09

115

(3052851) Hemolysis interference index of Serum or Plasma

148

954

1.58

6.30

5.1

3.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

239

1702

1.43

6.29

2.4

2.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

614

5039

1.26

6.19

1.1

1.2

u/ml

1.6

1.9

0.26

160

1276

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

481

3831

1.30

6.17

1.7

1.8

—

(3019225) pH of Specimen

420

3285

1.32

6.16

4.3

4.6

—

(3021589) Normoblasts [#/volume] in Blood

1399

12518

1.19

5.99

16.5

10.2

e9/l

0.0

0.41

1158

10185

(3021447) Carbon dioxide [Partial pressure] in Venous blood

414

3246

1.31

5.96

2.9

3.7

kpa

5.7

5.8

1.05

401

3138

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

119

743

1.62

5.82

2.5

2.2

218.2

202.3

1.08

114

713

(3002032) Base excess in Venous blood by calculation

411

3236

1.31

5.74

2.9

3.7

mmol/l

2.1

2.0

0.24

323

2594

(1616796) Gas panel - Central venous blood

123

779

1.60

5.68

3.7

4.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.00

5.52

1.3

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

116

732

1.60

5.45

2.1

2.6

umol/l

34.3

35.6

0.18

602

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

843

9713

0.83

5.38

2.1

2.2

u/l

217.3

222.9

0.07

788

9067

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

164

2.27

5.13

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

164

2.27

5.13

1.3

1.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

221

1621

1.39

4.97

2.6

3.8

mmol/l

24.2

24.1

0.16

205

1443

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

117

1761

0.65

4.93

2.2

2.4

au/ml

64.4

25.3

—

(4010399)

148

2117

0.69

4.81

1.3

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

225

2.01

4.65

1.2

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

2541

24173

1.18

4.58

31.4

18.2

37.5

39.0

11.10

1627

15417

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

227

1.99

4.54

1.2

1.4

—

(3035941) MCH [Entitic mass]

3127

30332

1.25

4.53

45.3

24.5

30.2

30.5

15.91

3088

29768

(3024731) MCV [Entitic volume]

3127

30333

1.25

4.52

45.4

24.5

91.4

91.7

2.70

3089

29769

(3026361) Erythrocytes [#/volume] in Blood

3127

30334

1.25

4.51

45.5

24.6

e12/l

4.3

4.4

74.27

3066

29307

(3010813) Leukocytes [#/volume] in Blood

3127

30339

1.25

4.47

45.6

24.6

e9/l

6.7

6.9

2.40

3066

29312

(3000963) Hemoglobin [Mass/volume] in Blood

3127

30339

1.25

4.47

45.8

24.7

g/l

127.1

134.4

119.97

3086

29781

(3007461) Platelets [#/volume] in Blood

3126

30329

1.25

4.47

45.5

24.6

e9/l

248.5

240.3

8.00

3068

29421

(3029937) Albumin [Presence] in Urine by Test strip

882

7749

1.18

4.39

4.4

4.2

estimate

0.0

0.34

309

2479

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1162

0.60

4.36

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

335

2669

1.28

4.30

4.9

3.9

mmol/l

1.2

1.28

300

2335

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

880

0.55

4.27

1.2

1.5

—

(3002385) Erythrocyte distribution width [Ratio]

2349

22259

1.16

4.26

39.2

20.4

14.6

13.9

60.96

2319

21712

(1002224) Polysomnography panel

826

0.54

4.23

1.0

1.1

—

(4094501)

813

0.54

4.23

1.0

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

556

1.60

4.20

3.8

3.7

59.4

58.7

0.19

556

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

976

0.58

4.19

1.2

1.5

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

536

1.60

4.10

3.3

e9/l

4.3

4.4

0.13

536

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

318

2536

1.28

4.06

4.7

2.8

ml/min/173m2

61.4

61.8

0.07

130

1073

(1761868) Lipid panel - Serum or Plasma

736

8401

0.84

4.04

2.9

3.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

149

1066

1.41

3.94

5.3

3.9

mmol/l

3.8

3.9

4.28

142

984

(3043410) Blood group antigens tested for on Red Blood Cells

2.54

3.79

2.4

2.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

104

701

1.50

3.76

1.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1350

12416

1.14

3.50

3.6

4.1

ng/l

34.6

91.9

1.05

1083

9523

(3008898) HLA-B27 [Presence]

609

0.52

3.45

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

736

0.57

3.42

1.3

1.7

mg/l

3.0

3.7

0.22

536

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

772

0.58

3.40

1.4

1.6

iu/ml

1.2

12.0

0.80

178

(40767503) Oxygen content in Capillary blood by calculation

107

747

1.45

3.29

2.8

2.5

15.1

15.9

0.93

390

(3013707) Erythrocyte sedimentation rate by Westergren method

2220

21145

1.13

3.18

3.4

4.2

mm/h

16.8

13.7

11.20

2015

19385

(3036489) Thrombin time

142

1049

1.37

3.17

2.1

1.9

20.9

21.6

1.20

134

951

(3022217) INR in Platelet poor plasma by Coagulation assay

562

4882

1.18

3.14

20.1

28.4

inr

1.3

1.4

1.50

681

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2415

25110

0.88

3.07

3.8

4.6

mu/l

2.1

0.36

2109

22487

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

261

2107

1.26

3.07

3.0

3.6

mmol/l

2.0

1.9

0.23

191

1538

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

291

1.69

3.06

1.2

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

5.01

3.05

1.1

1.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

244

0.37

3.04

1.0

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

696

1.43

2.97

1.7

—

(3027945) Reticulocytes/100 erythrocytes in Blood

478

4121

1.18

2.92

2.2

2.4

1.8

0.12

424

3616

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

718

6394

1.15

2.91

3.3

4.0

ng/l

400.7

548.2

0.34

598

5452

(3017446) Testosterone [Moles/volume] in Serum or Plasma

190

2406

0.78

2.89

1.9

2.1

nmol/l

10.6

12.3

1.83

159

2066

(3019832) Treponema pallidum Ab [Presence] in Serum

854

0.64

2.81

1.2

1.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

320

2670

1.22

2.79

2.7

3.0

kpa

4.5

0.11

307

2573

(3022806) Fractional oxyhemoglobin in Capillary blood

458

1.52

2.77

2.0

1.9

88.5

89.3

0.45

453

(3009343) pH of Capillary blood

265

2184

1.23

2.62

3.1

3.7

7.4

0.53

270

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

268

2215

1.23

2.58

3.1

3.7

kpa

5.1

5.2

0.42

246

2032

(3032773) Endomysium IgG Ab [Titer] in Serum

170

1.83

2.58

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

978

0.68

2.57

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

574

1.44

2.56

1.4

1.6

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

953

0.68

2.55

3.4

2.3

g/l

0.0

0.00

880

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

731

8087

0.88

2.50

3.0

3.2

ug/l

0.7

0.8

0.73

507

5744

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

584

0.60

2.47

1.1

1.5

e6/l

151.0

897.4

1.96

479

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

584

0.60

2.47

1.1

1.4

e6/l

4.6

26.3

1.34

451

(3005322) IgE [Units/volume] in Serum or Plasma

104

1397

0.74

2.47

1.2

1.3

u/ml

240.5

234.5

0.03

1271

(3009466) Valproate [Moles/volume] in Serum or Plasma

392

0.51

2.46

4.0

4.6

umol/l

340.9

339.5

0.01

336

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

216

2640

0.81

2.45

1.5

1.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

965

10483

0.89

2.44

4.3

4.0

mg/mmol

10.9

9.4

0.48

629

6750

(3033799) Differential panel - Peritoneal fluid

103

2.04

2.41

2.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1034

0.70

2.40

3.6

2.3

g/l

0.0

1.44

940

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

564

0.60

2.36

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1306

0.74

2.35

2.7

2.4

g/l

10.4

10.3

0.14

1104

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

971

0.69

2.35

3.3

2.3

g/l

0.0

0.00

882

(3021601) Nitrite [Presence] in Urine by Test strip

1487

13996

1.11

2.33

5.6

5.2

estimate

0.0

0.50

356

2630

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

239

2874

0.82

2.33

1.2

1.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

105

1393

0.75

2.31

2.9

2.3

g/l

3.8

0.13

996

(3023520) Reticulocytes [#/volume] in Blood

361

3109

1.18

2.27

2.3

2.5

e9/l

67.8

68.4

0.11

273

2379

(3000570) Elastase.pancreatic [Mass/mass] in Stool

114

863

1.33

2.27

1.3

1.5

ug/g

249.2

270.5

0.58

524

(3012516) Albumin [Mass/volume] in Urine

915

9926

0.89

2.23

3.4

3.3

mg/l

324.1

314.8

0.02

623

6424

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

106

1395

0.75

2.22

2.8

2.3

g/l

7.4

0.06

1035

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

106

1394

0.75

2.21

2.8

2.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

165

1.76

2.18

2.3

2.4

—

(3035350) Ketones [Presence] in Urine by Test strip

1482

13989

1.10

2.15

4.2

3.8

estimate

0.0

0.00

348

2605

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

283

1.56

2.11

1.3

1.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

571

0.63

2.11

1.1

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1191

0.74

2.10

3.1

2.5

g/l

0.7

1.2

1.33

1015

(44816559) Phosphatidylethanol [Mass/volume] in Blood

434

0.57

2.10

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

103

779

1.33

2.09

1.3

1.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

514

4578

1.14

2.08

1.4

1.5

g/l

2.7

0.06

286

2723

(3009508) Creatinine [Moles/volume] in Urine

935

10096

0.90

2.07

3.3

3.2

mmol/l

7.5

0.02

750

8375

(3020630) Protein [Mass/volume] in Serum or Plasma

253

2987

0.84

2.06

2.7

2.6

g/l

64.9

66.2

1.75

224

2704

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

721

1.34

2.04

1.2

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

721

1.34

2.04

1.2

1.3

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

4.00

2.04

1.0

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

893

0.71

1.98

1.2

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

311

0.51

1.97

1.3

1.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

208

2486

0.83

1.94

2.6

2.4

—

(21494755) Public health laboratory ask at order entry panel

100

1299

0.76

1.94

1.2

1.4

—

(3024263) Appearance of Synovial fluid

185

0.43

1.92

1.3

1.6

—

(3009261) Glucose [Presence] in Urine by Test strip

1496

14182

1.09

1.92

4.3

3.9

estimate

0.0

1.08

350

2534

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

164

1333

1.24

1.92

3.0

4.0

mmol/l

24.8

0.02

145

1218

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1061

11341

0.91

1.90

4.0

4.6

20.3

22.0

3.32

516

5957

(3026692) Albumin [Mass/volume] in Peritoneal fluid

1.96

1.89

1.3

1.5

g/l

11.9

14.2

0.67

(3015171) Extractable nuclear Ab [Units/volume] in Serum

919

0.72

1.89

1.1

1.2

u/ml

7.4

0.8

—

(3028707) Methadone [Presence] in Urine by Screen method

139

0.36

1.88

1.0

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

166

1.69

1.87

1.4

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

166

1.69

1.87

1.4

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

166

1.69

1.87

1.4

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

129

1.79

1.85

1.5

1.7

—

(40768443) Skin Pathology biopsy report

104

1334

0.77

1.85

1.1

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

115

1.83

1.82

1.3

2.5

e6/l

704.4

6917.4

0.50

(3021440) Promyelocytes/100 leukocytes in Blood

282

2430

1.17

1.81

3.0

4.1

0.2

0.1

1.21

109

725

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

581

1.35

1.79

1.0

1.1

u/ml

1.3

8.2

—

(3010503) CD19 cells [#/volume] in Blood

168

0.42

1.78

1.0

2.0

e9/l

0.1

—

159

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.44

1.75

1.0

1.1

ng/l

82.6

106.7

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

204

1715

1.20

1.74

3.2

3.5

mmol/l

24.4

25.2

1.81

193

1662

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

193

1.61

1.74

1.4

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

193

1.61

1.74

1.4

1.6

—

(3004809) Band form neutrophils/100 leukocytes in Blood

576

1.34

1.73

2.5

3.6

3.5

1.6

1.84

430

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

103

1.85

1.71

1.4

2.3

e6/l

22825.5

22264.4

0.01

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1182

0.77

1.68

1.8

u/l

37.8

38.2

0.06

1007

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1081

0.76

1.68

2.9

2.2

g/l

38.0

37.4

0.42

926

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

306

0.55

1.68

1.2

1.4

45.3

28.4

—

182

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

214

0.47

1.67

2.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

691

0.70

1.66

1.2

—

46.1

—

(3017181) Myelocytes/100 leukocytes in Blood

294

2562

1.16

1.65

3.1

4.1

1.2

0.9

1.36

119

780

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

145

0.41

1.64

1.2

1.0

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

748

1.29

1.64

1.3

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

127

1.74

1.64

1.5

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

127

1.74

1.64

1.5

1.7

—

(3022313) Gas panel - Capillary blood

188

1580

1.20

1.63

2.9

3.8

—

(3017569) Oxygen content in Arterial blood

181

1.61

1.63

1.9

2.3

—

(3014271) Vancomycin [Susceptibility]

197

1.58

1.62

2.8

3.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

133

0.38

1.61

6.6

6.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

166

1.63

1.61

1.4

1.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

124

1527

0.81

1.60

1.8

1.9

—

(3044007) Cell count panel - Peritoneal fluid

1.87

1.60

1.2

2.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

209

0.48

1.58

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

103

1292

0.79

1.57

2.9

2.4

g/l

3.0

3.1

0.22

1015

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

280

1.47

1.56

1.8

2.0

u/field

2.0

1.9

0.07

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

208

0.48

1.56

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

339

1.42

1.54

2.8

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

141

0.42

1.52

1.8

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

654

0.71

1.50

1.2

u/ml

1.7

5.3

—

106

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

108

1.76

1.50

1.8

2.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

140

1687

0.82

1.48

2.0

1.9

g/l

1.4

1.5

0.07

129

1518

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

170

1.59

1.48

1.4

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

170

1.59

1.48

1.4

1.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

129

0.39

1.48

1.0

—

13.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

777

0.74

1.47

1.4

1.6

e6/l

8703.9

15050.0

0.97

551

(1001926) Buprenorphine [Presence] in Urine by Screen method

229

0.52

1.46

1.0

1.5

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

187

1590

1.19

1.45

2.2

2.5

0.7

0.6

0.06

178

1517

(3000492) Spirometry study

207

2404

0.85

1.45

1.4

1.5

—

(3000012) Reticulocyte production index

187

1.56

1.45

1.3

1.5

—

(3045414) Leukocytes [Presence] in Urine

159

1333

1.20

1.44

2.4

1.9

—

(4034850)

943

0.77

1.43

12.8

11.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

115

1406

0.81

1.42

3.0

3.2

pmol/l

4.3

4.4

0.47

108

1217

(3002179) Metamyelocytes/100 leukocytes in Blood

264

2313

1.15

1.42

2.9

3.9

0.7

0.6

0.45

550

(3045424) Erythrocytes [Presence] in Urine

492

1.33

1.40

1.8

1.4

—

(36660697) Celiac disease serology panel - Serum

211

1821

1.17

1.38

1.1

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.08

1.38

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

104

1.73

1.36

1.0

—

(3001729) Color of Synovial fluid

0.00

1.34

0.0

1.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

866

0.77

1.34

2.5

2.3

ug/min

218.3

108.5

0.56

510

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

2.13

1.33

1.5

1.7

ug/l

0.8

2.9

—

(3044290) Cell count panel - Cerebral spinal fluid

535

0.71

1.33

1.1

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

216

1.49

1.33

1.1

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

591

0.72

1.31

1.4

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

283

1.42

1.31

1.4

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

283

1.42

1.31

1.4

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

283

1.42

1.31

1.4

1.5

—

(3003434) Protein [Mass/volume] in Pleural fluid

551

1.29

1.30

1.4

1.5

g/l

30.8

31.6

0.20

491

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

244

0.57

1.29

1.1

1.7

—

(4146454)

378

1.35

1.28

3.4

2.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

804

1.24

1.26

3.0

2.9

kpa

7.9

0.09

738

(3019897) Erythrocyte distribution width [Ratio] by Automated count

170

1.53

1.25

3.7

3.2

13.2

0.14

170

(3021901) Oxygen saturation in Capillary blood

688

1.26

1.25

3.0

2.9

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

118

0.42

1.24

1.0

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

119

0.42

1.24

1.0

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

372

1.35

1.24

1.3

1.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

228

1.45

1.24

1.4

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

459

1.31

1.23

1.3

1.6

—

(3019977) pH of Arterial blood

204

1.47

1.22

1.7

2.5

7.4

0.03

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.04

1.22

1.7

1.6

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.63

1.21

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.16

1.21

1.1

—

(3011288) Drugs identified in Urine by Screen method

188

0.53

1.20

1.0

2.1

—

(3021788) Differential panel - Synovial fluid

581

0.74

1.20

1.3

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

226

0.57

1.20

1.0

u/ml

2.6

4.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

438

4006

1.11

1.20

3.1

4.0

u/l

258.9

244.9

0.68

418

3770

(3001019) Free T4 and TSH panel - Serum or Plasma

738

0.77

1.18

1.5

1.7

—

(3011544) Albumin [Mass/volume] in Pleural fluid

2.11

1.18

1.0

1.1

g/l

22.2

16.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.88

1.18

1.1

—

(3016879) Cocaine [Presence] in Urine

274

0.62

1.18

1.0

1.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

165

1.52

1.17

2.1

1.9

—

(3023419) Bacteria identified in Sputum by Culture

440

0.70

1.17

2.3

2.6

—

(3025130) Human papilloma virus identified in Specimen

133

1.58

1.17

1.5

1.8

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

776

1.23

1.17

2.7

2.1

g/l

122.8

128.2

1.17

564

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.00

1.16

0.0

1.5

—

0.8

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

1.16

0.0

1.2

—

9.6

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

391

0.69

1.14

1.3

1.5

54.9

62.1

0.33

242

(3001893) Eosinophils/100 leukocytes in Pleural fluid

134

1.57

1.14

1.3

1.5

1.4

3.0

1.01

113

(4281824)

258

1.40

1.13

1.3

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

240

2128

1.14

1.13

2.6

3.2

g/l

123.7

128.3

2.46

233

2067

(3012441) Differential panel - Pleural fluid

431

1.30

1.12

1.4

1.5

—

(3037556) Urate [Mass/volume] in Serum or Plasma

113

0.44

1.12

1.4

1.5

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.34

1.12

1.9

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

221

0.59

1.12

1.0

1.1

u/ml

1.8

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

306

0.65

1.11

1.4

1.3

e6/l

9183.0

110757.3

1.99

215

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

220

0.59

1.10

1.1

1.2

mmol/l

2.9

2.1

1.00

203

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

415

1.31

1.10

1.3

1.5

pmol/l

257.7

258.9

0.00

405

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.26

1.10

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

549

0.74

1.10

1.8

iu/l

6.4

4.3

0.30

171

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

381

1.32

1.08

1.3

u/l

282.4

334.0

0.40

360

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.73

1.08

1.1

1.0

—

(3025159) Blasts/100 leukocytes in Blood

254

2268

1.13

1.08

3.1

4.1

0.6

0.3

0.24

602

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.19

1.08

2.4

2.5

u/field

0.6

—

(3027008) Opiates [Presence] in Urine

291

0.65

1.07

1.0

1.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

774

7298

1.08

1.07

4.6

3.6

—

(3002619) Bacteria identified in Specimen by Culture

1.93

1.06

1.5

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

219

2463

0.88

1.04

3.0

4.0

ng/l

94.2

99.6

0.32

181

2097

(3005719) IgG [Mass/volume] in Serum or Plasma

187

2124

0.87

1.04

2.5

2.7

g/l

9.7

10.7

2.40

171

1926

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.06

1.02

1.3

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.74

1.02

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1.92

1.02

1.2

1.4

—

(3005033) Fetal Nuchal fold Thickness US

1.92

1.02

1.2

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

586

0.76

1.01

1.1

1.3

u/l

52.5

40.8

0.22

511

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1.89

1.01

1.2

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1.89

1.01

1.2

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1.89

1.01

1.2

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1.89

1.01

1.2

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

107

0.47

1.01

1.0

—

(3037756) Immunofixation for Serum or Plasma

796

0.80

1.00

1.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

248

1.37

0.99

1.0

1.1

u/ml

4.1

2.2

0.46

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

379

0.71

0.99

1.1

1.2

miu/ml

309.1

196.3

—

133

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1.84

0.98

1.3

1.5

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

134

0.52

0.98

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.00

0.97

0.0

1.1

—

80.2

—

(3016018) Differential panel - Cerebral spinal fluid

272

0.66

0.97

1.1

1.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.97

0.0

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

259

0.65

0.96

1.0

1.1

u/ml

1.6

1.9

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

347

3180

1.10

0.95

2.3

2.9

ng/l

234.4

228.4

0.09

310

2918

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.95

0.0

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

191

1.42

0.94

1.9

2.2

ug/min

64.8

162.8

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

375

0.72

0.94

2.9

3.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

660

1.22

0.94

1.1

1.2

—

(3028300) Cannabinoids [Presence] in Urine

293

0.68

0.93

1.0

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

498

1.25

0.93

1.2

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

146

0.55

0.92

1.4

1.6

—

9.7

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1.82

0.92

1.3

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

291

0.69

0.91

1.0

1.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1338

13850

0.95

0.90

2.2

2.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

230

0.65

0.88

1.1

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

728

0.81

0.88

3.7

3.5

mg/l

36.6

29.5

0.51

462

(40768800) Prostate Pathology biopsy report

945

0.83

0.87

1.2

—

(3000494) Fungus identified in Specimen by Culture

373

3447

1.09

0.87

1.5

1.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

186

1.40

0.87

1.5

1.6

u/l

13.9

6.1

0.74

(3009214) Lutropin [Units/volume] in Serum or Plasma

470

0.76

0.86

1.4

1.3

u/l

22.9

9.8

2.66

381

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

647

0.80

0.85

1.7

1.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

442

1.25

0.84

1.4

e6/l

23478.5

81675.3

2.13

265

(3027944) Amphetamines [Presence] in Urine

286

0.70

0.84

1.0

1.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

360

3886

0.92

0.83

4.4

4.8

32.9

0.00

232

2539

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1111

11534

0.95

0.82

2.1

2.2

nmol/l

76.3

78.6

1.70

969

10098

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

444

1.24

0.82

1.2

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

488

0.78

0.81

1.4

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

177

0.62

0.81

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

147

1.43

0.80

1.4

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

113

1299

0.87

0.79

1.2

iu/ml

188.6

140.9

0.51

457

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

192

1725

1.12

0.79

1.6

1.7

g/l

1.7

1.6

1.35

165

1477

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.79

0.0

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

108

934

1.16

0.79

3.1

3.2

mmol/l

24.3

25.1

0.78

808

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

106

1.51

0.78

1.3

1.7

—

(3020650) Glucose [Presence] in Urine

1.67

0.78

1.5

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

271

2483

1.10

0.78

1.3

1.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.62

0.78

1.7

2.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

241

2641

0.91

0.78

1.5

1.7

1.6

0.03

206

2245

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.77

0.76

1.2

1.1

—

(3014891) Appearance of Pleural fluid

1.70

0.75

2.3

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

161

0.62

0.75

1.1

1.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

613

5812

1.07

0.75

4.1

4.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

486

1.22

0.75

1.5

1.4

e6/l

872.0

1817.5

3.88

348

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

570

0.80

0.75

1.2

1.1

—

9.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

230

2518

0.91

0.74

1.8

2.2

nmol/l

403.5

371.8

1.60

214

2288

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

132

0.61

0.73

1.1

1.2

—

(3023410) Appearance of Cerebral spinal fluid

254

0.71

0.73

1.1

1.5

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

106

0.57

0.72

1.2

1.3

41.8

59.2

—

(3016228) CD19 cells/100 cells in Blood

110

0.54

0.72

1.0

1.9

9.3

7.7

—

103

(3000093) Morphology [Interpretation] in Blood Narrative

317

1.26

0.71

1.1

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.58

0.71

2.7

2.3

mmol/l

8.7

8.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

158

0.63

0.70

2.1

1.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

442

0.79

0.68

1.1

1.2

—

(3049717) Cytology report of Urine Cyto stain

171

1543

1.11

0.68

2.8

—

(3019150) Specific gravity of Urine by Refractometry

594

6240

0.94

0.67

4.1

4.3

kg/l

1.0

0.12

971

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

102

1162

0.87

0.66

2.9

3.4

ratio

1.4

2.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

626

0.83

0.66

1.9

1.5

—

(4015189)

0.53

0.66

1.4

2.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

777

0.85

0.66

1.4

1.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

711

6801

1.06

0.66

3.4

3.8

—

(3044242) Glucose [Moles/volume] in Arterial blood

197

1.32

0.65

2.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

171

1.35

0.65

2.3

1.5

u/l

216.1

2346.3

0.65

(3017354) Segmented neutrophils/100 leukocytes in Blood

358

1.23

0.65

2.5

3.7

57.4

57.9

0.04

217

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

304

1.25

0.65

1.9

1.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

213

0.70

0.64

1.3

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.72

0.64

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

341

1.23

0.63

1.2

1.3

—

(4027681)

130

0.61

0.63

1.1

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

155

1.36

0.62

1.0

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

200

0.70

0.62

1.0

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

190

1.32

0.62

5.9

13.0

—

(1175426) CD3 cells/100 lymphocytes in Blood

188

0.69

0.62

1.2

2.0

65.3

71.5

1.02

173

(21494814) CD8 cells/100 lymphocytes in Specimen

103

0.58

0.62

1.0

1.9

—

(21494890) Protein electrophoresis panel - 24 hour Urine

391

0.79

0.62

2.7

2.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

147

1.36

0.61

1.4

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.46

0.61

1.4

1.5

—

(3035880) pH of Pleural fluid

226

1.29

0.61

1.2

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

453

1.19

0.60

1.3

1.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.00

0.60

0.0

1.1

—

(3024316) Viscosity of Plasma

0.00

0.60

0.0

1.5

—

1.7

—

(3019174) dRVVT (LA screen)

0.00

0.60

0.0

1.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

165

1.34

0.60

1.2

1.4

43.9

67.8

1.48

131

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

618

0.84

0.60

1.2

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.59

0.0

1.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

0.00

0.59

0.0

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

243

0.74

0.59

1.2

—

28.4

—

(3052592) Norovirus Ag [Presence] in Stool

1.56

0.58

1.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.58

0.0

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

115

0.61

0.57

1.0

1.2

—

1.1

—

(3044941) Cell count panel - Synovial fluid

518

0.83

0.57

1.3

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

401

1.20

0.57

7.1

23.6

mmol/l

6.7

7.6

2.07

333

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.48

0.57

1.2

—

(3004775) Volume in Urine collected for unspecified duration

286

0.77

0.56

1.8

2.2

667.0

646.5

0.13

177

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

263

0.76

0.56

1.0

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.62

0.55

1.0

1.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1080

10486

1.04

0.55

2.6

3.2

ng/l

1481.6

1733.2

1.35

951

9127

(3017732) Neutrophils [#/volume] in Blood

200

1846

1.09

0.54

4.1

3.4

e9/l

4.1

4.3

0.36

153

1338

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

124

0.64

0.54

2.1

2.0

umol/l

53.8

55.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.58

0.54

1.0

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

350

0.80

0.54

1.0

1.4

—

(4133840)

1.45

0.53

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

107

1192

0.89

0.53

2.9

3.4

mg/l

53.3

108.8

0.60

968

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

360

0.80

0.53

1.0

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1102

10715

1.04

0.52

4.6

4.2

—

(3014051) Protein [Presence] in Urine by Test strip

713

1.14

0.52

2.8

2.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

181

0.72

0.52

1.2

2.0

18.9

15.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

107

1191

0.90

0.52

2.9

3.4

mg/l

35.1

66.4

1.76

970

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

225

2417

0.93

0.52

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

323

1.21

0.52

1.9

1.6

—

(3000330) Specific gravity of Urine by Test strip

157

1712

0.91

0.51

6.3

3.6

—

(40768806) Pleura Pathology biopsy report

434

1.18

0.51

1.4

1.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

110

1220

0.90

0.51

2.1

2.6

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

297

1.21

0.50

1.3

u/l

9.8

13.7

1.29

272

(3024928) Oxygen saturation in Venous blood

736

1.13

0.49

1.4

2.7

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

178

0.73

0.48

1.2

2.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

110

0.64

0.48

1.4

1.3

—

(44813793)

143

0.70

0.47

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

146

1.30

0.47

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

146

1.30

0.47

1.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

176

0.74

0.46

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

176

0.74

0.46

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

176

0.74

0.46

1.2

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.62

0.45

1.0

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

264

1.21

0.45

1.1

u/ml

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

554

1.14

0.44

1.2

1.4

—

(40768793) Breast Pathology biopsy report

501

0.86

0.43

1.4

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

490

0.86

0.43

1.2

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

404

0.84

0.43

1.2

u/ml

200.6

299.6

2.18

240

(3035637) Corticotropin [Mass/volume] in Plasma

338

0.83

0.42

1.3

1.6

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

173

0.75

0.42

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

173

0.75

0.42

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

173

0.75

0.42

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

305

0.82

0.41

1.0

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

283

0.81

0.41

1.0

1.2

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

1.0

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

1.9

—

1.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

(3047189) Immunofixation for 24 hour Urine

183

0.76

0.40

1.8

1.7

—

(3045716) Anion gap in Serum or Plasma

177

1.24

0.40

2.4

2.3

mmol/l

8.9

9.3

0.26

138

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.40

0.0

1.5

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.40

0.0

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.40

0.0

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

101

0.69

0.39

1.1

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1.31

0.39

1.3

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

103

0.68

0.39

1.0

2.1

—

31982.7

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.43

0.39

1.0

—

9.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.39

0.0

1.4

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.39

0.0

1.0

—

(21491868) Cryoglobulin [Mass/volume] in Serum

106

0.66

0.39

1.1

1.3

—

0.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

291

0.82

0.38

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

388

4046

0.95

0.38

11.6

7.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

364

1.16

0.37

3.2

4.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

113

0.71

0.37

1.0

1.4

—

(3045788) Cell count panel - Pleural fluid

383

1.15

0.37

1.6

1.4

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

158

0.76

0.37

1.4

1.7

nmol/l

17.3

15.9

0.22

144

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

0.64

0.35

1.2

1.1

pmol/l

163.8

266.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.64

0.35

1.2

1.4

ug/l

10.6

9.2

—

(3042631) Mycobacterium sp identified in Specimen

500

1.12

0.34

1.8

2.8

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

127

1.26

0.33

1.1

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

109

1.29

0.33

1.1

—

(3013727) Leukocytes other/100 leukocytes in Blood

118

1.27

0.33

1.5

3.6

65.6

54.7

1.37

113

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

0.67

0.33

1.0

1.9

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

603

0.89

0.32

1.3

1.5

nmol/l

1.0

0.8

0.74

494

(3035933) Granulocytes/100 leukocytes in Blood

1.28

0.32

1.3

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

211

1.19

0.31

2.7

2.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

903

0.92

0.31

2.7

3.6

—

(3044927) Protein electrophoresis panel - Urine

390

0.87

0.31

1.1

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.71

0.30

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

421

0.88

0.30

1.1

iu/ml

193.3

66.8

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

571

1.11

0.30

2.0

5.0

iu/ml

264.5

3660.4

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.30

0.30

1.1

umol/l

18.6

16.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.31

0.30

1.2

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

249

2380

1.05

0.30

1.3

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

196

0.82

0.30

3.1

3.8

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

141

0.78

0.29

1.1

—

(21494434) Karyotype in Bone marrow

334

0.87

0.28

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

270

0.85

0.28

2.1

1.5

u/ml

32.2

24.4

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

103

1.26

0.28

1.3

1.4

17.9

23.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

103

1.26

0.28

2.2

1.3

umol/l

16.0

15.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.32

0.28

1.2

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

299

1.14

0.27

1.1

1.2

u/l

104.9

58.6

0.41

205

(3024869) Neuronal Ab [Presence] in Serum

1.23

0.27

1.0

1.1

—

(40768797) Stomach Pathology biopsy report

397

4096

0.97

0.26

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

300

1.13

0.26

2.1

2.0

—

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

780

0.92

0.26

2.6

2.9

mg/l

1.8

1.7

0.66

696

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

0.68

0.26

1.0

1.2

129.8

94.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.68

0.26

1.0

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

224

0.85

0.25

1.1

—

(4062490)

245

0.86

0.25

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.20

0.25

1.1

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

340

1.12

0.24

1.3

1.2

u/ml

3.0

5.1

1.05

158

(40757373) Influenza virus identified in Isolate

0.73

0.24

1.3

1.4

—

(3022689) Creatine [Moles/volume] in Urine

0.71

0.24

1.3

1.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1398

14147

0.98

0.23

4.6

5.4

ug/l

2.7

4.0

2.06

1200

12592

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.28

0.23

1.0

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

168

0.83

0.22

1.1

1.4

u/ml

0.1

1.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

400

0.90

0.22

1.4

1.5

—

(3015183) Erythrocyte sedimentation rate

0.77

0.22

1.4

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.25

0.22

2.4

2.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.27

0.22

1.0

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1040

0.94

0.22

1.6

1.5

titre

193.3

228.4

—

(3005570) Glucose [Moles/volume] in Urine

314

1.12

0.22

1.7

2.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

146

0.82

0.22

1.0

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.22

0.22

2.4

2.2

—

(3003338) MCHC [Mass/volume]

2215

22308

0.98

0.22

40.9

22.1

g/l

330.0

332.0

20.55

2197

22087

(3021960) Folate [Moles/volume] in Serum or Plasma

770

7836

0.98

0.21

1.7

1.6

nmol/l

19.8

20.0

0.13

657

6614

(3013139) Helicobacter pylori Ag [Presence] in Stool

169

1764

0.96

0.21

1.2

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

792

0.93

0.21

3.1

nmol/l

0.7

0.8

1.34

597

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

2.5

—

(3042517) Benzodiazepines panel - Urine

0.00

0.21

0.0

1.4

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.1

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.21

0.0

1.4

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.21

0.0

1.4

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.2

—

3.7

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

5.6

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

101

0.79

0.21

5.4

1.6

234.3

182.5

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

102

0.78

0.21

1.5

2.0

ug/l

81.1

49.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

126

1.19

0.21

1.2

1.1

—

(4306422)

325

1.11

0.21

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

192

1.15

0.20

1.5

1.2

mmol/l

10.0

12.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.20

0.0

4.9

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.20

0.0

1.0

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.20

0.0

1.0

—

10.8

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

187

0.85

0.20

1.2

1.4

umol/l

15.9

14.4

0.26

174

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

183

1.15

0.20

2.4

1.9

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

114

0.79

0.20

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

469

0.92

0.20

1.2

1.3

—

(3048879) Bone marrow aspiration report

115

0.78

0.20

1.1

1.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

931

0.94

0.19

4.8

4.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.15

0.19

1.2

1.5

—

(40768795) Lymph node Pathology biopsy report

269

0.89

0.18

1.3

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

713

0.94

0.18

1.4

g/l

0.3

0.2

0.55

674

(3036603) Volume of Urine

214

1.12

0.17

2.0

1.5

1781.0

1858.1

—

(3004451) EKG impression Narrative

176

1.14

0.17

1.3

—

(3006270) Folate [Moles/volume] in Blood

278

0.90

0.17

1.3

1.2

nmol/l

355.8

328.4

0.26

227

(3023511) Choriogonadotropin [Units/volume] in Urine

0.73

0.17

1.2

1.3

—

(3004616) Nuclear Ab [Presence] in Serum

340

0.91

0.16

1.1

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

484

0.93

0.16

1.5

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

350

1.09

0.16

1.3

1.2

u/ml

5.3

3.8

0.21

112

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

204

0.88

0.16

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

463

0.93

0.16

3.4

2.5

—

(3008295) Osmolality of Serum or Plasma

318

0.91

0.15

1.3

mosm/kgh2o

275.1

276.7

0.17

229

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.79

0.15

1.0

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.79

0.15

1.8

1.7

ug/l

0.9

1.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

624

6144

1.02

0.15

1.6

1.7

mg/l

2.3

1.5

2.60

509

4817

(3034426) Prothrombin time (PT)

0.75

0.15

1.2

1.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.75

0.15

1.0

1.1

—

(3017704) Immunofixation for Urine

213

0.89

0.15

1.3

1.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1313

13241

0.99

0.14

2.1

pmol/l

86.7

93.0

5.59

770

6960

(46235355) HIV 1 and 2 tests - Meaningful Use set

278

2843

0.98

0.13

1.3

1.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

387

0.93

0.13

1.4

1.6

g/l

1.2

0.9

0.35

296

(3045142) Bone marrow Pathology biopsy report

393

1.07

0.13

1.2

1.3

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

242

0.91

0.13

1.4

1.3

g/l

6.0

7.1

0.79

171

(3028192) IgG subclass 2 [Mass/volume] in Serum

242

0.91

0.13

1.4

1.3

g/l

2.3

3.0

1.95

172

(3024139) IgG subclass 3 [Mass/volume] in Serum

242

0.91

0.13

1.4

1.3

g/l

0.3

0.4

1.44

171

(3025577) Chromium [Mass/volume] in Blood

221

0.90

0.12

1.8

2.1

ug/l

2.0

1.9

0.07

183

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

219

1.10

0.12

1.1

—

4.3

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

375

1.07

0.12

2.8

3.7

nmol/l

9.8

21.3

0.33

369

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

522

1.05

0.12

3.3

3.4

—

(3016750) Collection duration of Urine

199

0.90

0.11

1.9

2.0

min

493.1

493.2

0.00

142

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

435

1.06

0.11

1.5

2.2

mg/l

48.7

23.9

0.62

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

779

1.04

0.11

1.2

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

221

1.09

0.11

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

309

1.07

0.10

3.2

mg/l

45.5

31.5

0.39

243

(3027923) C peptide [Moles/volume] in Serum or Plasma

154

1.10

0.10

1.4

1.3

nmol/l

1.2

1.1

0.19

116

(3021879) Hepatitis B virus core Ab [Presence] in Serum

148

1516

0.98

0.09

1.2

1.4

—

(44790049)

340

0.94

0.09

1.3

1.5

—

(44790048)

340

0.94

0.09

1.3

1.5

—

(44790047)

340

0.94

0.09

1.3

1.5

—

(44806118)

340

0.94

0.09

1.3

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.04

0.09

1.0

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

421

0.95

0.09

1.2

1.4

u/ml

78.5

120.7

—

(4024509)

308

0.94

0.08

1.8

1.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.08

0.08

1.4

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

470

0.96

0.08

1.2

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

254

1.06

0.07

1.2

1.6

—

(3029075) Extractable nuclear Ab panel - Serum

0.84

0.07

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.83

0.07

1.3

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.82

0.07

1.2

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

662

0.97

0.07

1.3

1.6

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.80

0.07

1.0

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

886

1.03

0.07

1.9

1.5

—

(40765096) Chromosome analysis panel by Banding

108

1.11

0.07

1.2

1.1

—

(3006245) CD3-CD19+ cells/100 cells in Blood

0.86

0.07

1.3

2.0

18.4

8.8

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

0.86

0.07

1.3

2.0

25.9

29.3

—

(3016244) Insulin [Units/volume] in Serum or Plasma

0.89

0.06

2.9

2.8

mu/l

14.4

20.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.86

0.06

1.0

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

404

1.04

0.06

1.1

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

141

0.92

0.05

1.2

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

899

0.98

0.05

1.6

—

(3006653) Thiamine [Moles/volume] in Blood

151

0.93

0.05

1.0

1.2

nmol/l

154.6

138.6

0.30

151

(3022621) pH of Urine by Test strip

204

2018

1.01

0.04

3.4

3.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

170

1.06

0.04

3.6

3.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

655

6579

0.99

0.04

1.7

1.8

nmol/l

1186.2

1166.6

0.18

496

4898

(44806420)

119

0.92

0.04

2.5

2.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

129

0.93

0.03

1.7

2.4

—

(4211845)

151

1.06

0.03

4.8

3.8

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

479

1.02

0.03

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

350

0.97

0.03

1.2

1.4

pmol/l

210.5

270.2

1.01

269

(40761535) Cells panel - Urine sediment

273

2712

1.01

0.03

3.0

3.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

561

0.98

0.03

1.1

1.2

—

(3011985) Renin [Units/volume] in Plasma

380

0.97

0.03

1.3

1.4

mu/l

39.8

71.1

1.40

339

(3003181) Sodium [Moles/volume] in Urine

599

1.02

0.02

1.5

1.3

mmol/l

70.5

61.8

0.66

478

(3011648) Oxygen content in Venous blood

261

1.03

0.02

1.1

1.8

10.8

10.9

0.06

261

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

408

0.98

0.01

1.0

—

(40768446) Kidney Pathology biopsy report

106

0.94

0.01

1.4

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

126

0.95

0.00

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

136

0.96

0.00

1.0

1.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

110

1.00

0.00

1.5

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

110

1.00

0.00

1.5

2.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

110

1.00

0.00

1.5

1.6

umol/l

72.2

106.9

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

131

0.99

0.00

2.0

93.7

96.5

0.11

126

(3023323) Follitropin [Units/volume] in Serum or Plasma

432

1.00

0.00

1.2

1.3

iu/l

46.5

31.7

1.65

363

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

741

1.00

0.00

1.4

g/l

1.1

1.2

0.27

699

(3003740) Influenza virus B Ag [Presence] in Specimen

255

1.02

0.00

1.0

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

382

0.99

0.00

1.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

339

1.00

0.00

1.2

1.3

nmol/l

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

368

1.01

0.00

1.6

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

330

1.00

0.00

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

324

3241

1.00

0.00

1.9

2.4

ug/l

5.8

7.3

1.13

274

2815

(3006462) Nitrate [Presence] in Urine

141

0.99

0.00

5.0

3.9

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

141

0.99

0.00

1.1

1.2

mmol/l

5.9

6.2

0.39

134

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.03

0.00

1.0

1.2

—

(4268621)

235

1.02

0.00

2.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

256

1.02

0.00

1.0

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

346

1.01

0.00

1.2

1.3

—

(3038026) Centromere Ab [Units/volume] in Serum

243

0.99

0.00

1.1

—

54.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

690

6904

1.00

0.00

1.7

pmol/l

15221709.0

25355283.5

0.27

565

5636

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

5.8

—

50.6

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.0

1.0

—

46.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.3

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.89

0.00

5.1

7.6

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

498.8

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.94

0.00

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.0

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.98

0.00

5.6

7.5

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.0

2.3

—

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.86

0.00

1.0

1.3

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.4

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.2

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

0.0

1.1

—

0.2

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1687.4

—

(3028433) Virus identified in Specimen by Culture

0.94

0.00

1.3

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

0.95

0.00

5.4

1.7

215.3

213.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.98

0.00

1.0

1.1

—

(3022229) Phosphate [Moles/volume] in Urine

0.00

0.0

1.0

—

19.8

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.3

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

3.7

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.92

0.00

1.0

1.5

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.89

0.00

1.0

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

1.00

0.00

2.4

2.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint C3_RECTUM_ADENO and mortality.

Females

Parameter	HR [95% CI]	p-value
C3_RECTUM_ADENO	2.736 [2.47, 3.04]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.147

During the follow-up period (1.1.1998 — 31.12.2019), 3757 out of 7528 females with C3_RECTUM_ADENO died.

Males

Parameter	HR [95% CI]	p-value
C3_RECTUM_ADENO	2.683 [2.41, 2.99]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.006

During the follow-up period (1.1.1998 — 31.12.2019), 5642 out of 10593 males with C3_RECTUM_ADENO died.

Mortality risk

Mortality risk for people of age

years, who have C3_RECTUM_ADENO.

N-year risk	Females	Males
1	0.436%	0.519%
5	1.75%	2.748%
10	4.207%	7.496%
15	8.114%	13.755%
20	13.161%	22.668%

Relationships between endpoints

↥

Index endpoint: C3_RECTUM_ADENO – Adenocarcinoma and papilloma adenocarcinoma of rectum

GWS hits: 8

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Adenocarcinoma and papilloma adenocarcinoma of rectum

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints